LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 63.39 | 770.25 | 8196 | 9326 | 0.8788 | 0.9295 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 65.61 | 770.25 | 8956 | 9736 | 0.9199 | 0.9549 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 65.61 | 770.25 | 8746 | 9736 | 0.8983 | 0.9423 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 67.83 | 770.25 | 9391 | 10078 | 0.9318 | 0.9623 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 67.83 | 770.25 | 9137 | 10078 | 0.9066 | 0.9478 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.05 | 770.25 | 9681 | 10413 | 0.9297 | 0.9615 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.05 | 770.25 | 9456 | 10413 | 0.9080 | 0.9493 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 72.27 | 770.25 | 10057 | 10730 | 0.9372 | 0.9662 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 72.27 | 770.25 | 9883 | 10730 | 0.9210 | 0.9572 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 74.50 | 770.25 | 10288 | 10991 | 0.9360 | 0.9658 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 74.50 | 770.25 | 10211 | 10991 | 0.9290 | 0.9620 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 76.75 | 770.25 | 10614 | 11262 | 0.9424 | 0.9696 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 76.75 | 770.25 | 10520 | 11262 | 0.9340 | 0.9651 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 78.98 | 770.25 | 11000 | 11518 | 0.9550 | 0.9765 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 78.98 | 770.25 | 10949 | 11518 | 0.9506 | 0.9742 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.20 | 770.25 | 11307 | 11766 | 0.9610 | 0.9799 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.20 | 770.25 | 11355 | 11766 | 0.9650 | 0.9820 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 83.42 | 770.25 | 11441 | 12031 | 0.9509 | 0.9748 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 83.42 | 770.25 | 11771 | 12031 | 0.9783 | 0.9890 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.64 | 770.25 | 11776 | 12287 | 0.9584 | 0.9788 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 85.64 | 770.25 | 12160 | 12287 | 0.9896 | 0.9948 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 770.25 | 12030 | 12543 | 0.9591 | 0.9793 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 770.25 | 12603 | 12543 | 1.0048 | 1.0024 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.21 | 770.25 | 987 | 904 | 1.0911 | 1.9119 | MN20160304_L02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 3.21 | 770.25 | 937 | 904 | 1.0358 | 1.3273 | MN20160304_L02 | N21 |